In a joint project with AG Stegmann and Dr. Youn (University Stuttgart) funded by the Baden-Württemberg Stiftung we aim to generate novel, resistance-breaking antibiotics by mutasynthesis approaches. Focus of the study are two groups of natural compounds (glycopeptides and streptogramins), which are used as antibiotics of last resort in medical therapy. We aim to optimize both antibiotic groups by altering the biologically relevant phenylglycine-residues of the compounds with the help of mutasynthesis approaches. The generated glycopeptide and streptogramin derivatives shall have improved antibiotic activities and resistance-breaking characteristics.